37 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
18 Apr 11
Ligand Names Matthew W. Foehr Chief Operating Officer
12:00am
R&D Operations, Senior Vice President of Product Development & Support, and Vice President of Supply Chain Technical Services. Prior to Stiefel, Mr
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
2 Feb 15
Departure of Directors or Certain Officers
12:00am
& Support, and Vice President of Global Supply Chain Technical Services. Prior to Stiefel, Mr. Foehr held various executive roles at Connetics
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
18 Apr 11
Ligand Names Matthew W. Foehr Chief Operating Officer
12:00am
of Product Development & Support, and Vice President of Supply Chain Technical Services. Prior to Stiefel, Mr. Foehr held various executive roles
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
18 Nov 14
Regulation FD Disclosure
12:00am
granted and pending 66 Multi-metric ton cGMP supply chain using highest- quality partner and pharmaceutical standards
68 Adapted from Williams, et al … and surfactants) Lipid emulsions Nano-milled drug crystals/particle engineering Liposomes, polymeric or lipid nanoparticles
Supply Chain Distribution
8-K
EX-99.1
mbxhmz1o8kew5c1w7
6 May 20
Ligand Reports First Quarter 2020 Financial Results
4:03pm
8-K
EX-99.1
3g2h6ngp5 5kqr
4 Dec 12
Regulation FD Disclosure
12:00am
8-K
EX-99.1
kyitppdows6b1jaqi sv
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K/A
EX-99.1
5oroheku0e0i
10 Dec 20
Financial Statements and Exhibits
4:13pm